Literature DB >> 14015587

In vitro studies of ulcerative colitis. I. Reactions of patients' serum with human fetal colon cells in tissue cultures.

O BROBERGER, P PERLMANN.   

Abstract

By means of immunofluorescent methods it has been shown that sera from children with ulcerative colitis contain antibodies which react with fetal colon cells in tissue culture. 5 out of 13 sera from patients reacted positively when tested for staining antibodies while 12 sera from healthy individuals yielded negative results. The specificity of the staining reactions was confirmed by inhibition experiments. The staining capacity of various sera was correlated to their hemagglutinating titer when tested against phenol-water extracts of human colon. The presence of blood group substances of the ABO system on fetal colon cells in tissue culture could be demonstrated by application of fluorescent H agglutinins from eel. Cross-inhibition experiments indicated that the H agglutinins stained colon antigens which were different from those reacting with the antibodies of ulcerative colitis sera. The reactivity of cultured fetal colon cells with the antibodies in ulcerative colitis sera was retained for up to 12 days, with optimal staining at 4 to 5 days. Reactivity with H agglutinins was present for a longer period, sometimes more than 20 days. Although antigen could be shown to be present on fetal colon cells in tissue culture, exposure of the culture, in the presence of fresh guinea pig serum, to sera from patients with ulcerative colitis did not lead to any visible cytotoxic damage. In order to investigate the possible cytotoxic effect of the sera with a more sensitive technique, freshly explanted fetal colon was dispersed by trypsinization and the cells labeled with (32)P-orthophosphate. Subsequently, these cells were exposed to sera, in a final concentration of 30 per cent, from patients or healthy controls in the presence of fresh guinea pig serum (final concentration 15 per cent). Approximately 20 per cent of the cellular isotope was released into the medium within 150 minutes of incubation, but the release was the same in the samples treated either with patients' sera or normal control sera. Thus, under the present conditions, the patients' sera did not exert any specific cytotoxic action on colon cells.

Entities:  

Keywords:  ANTIGEN-ANTIBODY REACTIONS; BLOOD; COLITIS, ULCERATIVE; COLON; TISSUE CULTURE

Mesh:

Substances:

Year:  1963        PMID: 14015587      PMCID: PMC2137646          DOI: 10.1084/jem.117.5.705

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Incidence of haemagglutinating and complement-fixing antibodies.

Authors:  G L ASHERSON; O BROBERGER
Journal:  Br Med J       Date:  1961-05-20

2.  The thyroid cytotoxic autoantibody.

Authors:  I J FORBES; I M ROITT; D DONIACH; I L SOLOMON
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

3.  Results of species-specific hemagglutination tests on "transformed," nontransformed, and primary cell cultures.

Authors:  K G BRAND; J T SYVERTON
Journal:  J Natl Cancer Inst       Date:  1962-01       Impact factor: 13.506

4.  The action of antibody and complement on mammalian cells.

Authors:  H GREEN; B GOLDBERG
Journal:  Ann N Y Acad Sci       Date:  1960-05-31       Impact factor: 5.691

5.  On the permeability to lissamine green and other dyes in the course of cell injury and cell death.

Authors:  B HOLMBERG
Journal:  Exp Cell Res       Date:  1961-01       Impact factor: 3.905

6.  Cytotoxic effects of Hashimoto serum on human thyroid cells in tissue culture.

Authors:  R J PULVERTAFT; D DONIACH; I M ROITT; R V HUDSON
Journal:  Lancet       Date:  1959-08-29       Impact factor: 79.321

7.  The in vitro uptake of fluorescein labelled plasma proteins. I. Mature cells.

Authors:  H HOLTZER; S HOLTZER
Journal:  C R Trav Lab Carlsberg       Date:  1960

8.  In vitro studies with antisera against tumor cell protein fractions.

Authors:  J S COLTER; D KRITCHEVSKY; H H BIRD; R F MCCANDLESS
Journal:  Cancer Res       Date:  1957-05       Impact factor: 12.701

9.  Studies on the Cytotoxic Factor in Thyroid Disease.

Authors:  W J Irvine
Journal:  Br Med J       Date:  1962-05-26

10.  Demonstration of an epithelial antigen in colon by means of fluorescent antibodies from children with ulcerative colitis.

Authors:  O BROBERGER; P PERLMANN
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

View more
  27 in total

1.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

2.  THE CYTOPLASMIC AUTO-ANTIGEN OF THE HUMAN THYROID. I. IMMUNOLOGICAL AND BIOCHEMICAL CHARACTERISTICS.

Authors:  I M ROITT; N R LING; D DONIACH; K G COUCHMAN
Journal:  Immunology       Date:  1964-07       Impact factor: 7.397

Review 3.  The immunology of inflammatory bowel disease.

Authors:  J R Lowes; D P Jewell
Journal:  Springer Semin Immunopathol       Date:  1990

Review 4.  Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.

Authors:  K M Das
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

5.  Antibodies to colonic epithelial cells from the serum and colonic mucosal washings in ulcerative colitis.

Authors:  U Y Khoo; I Bjarnason; A Donaghy; R Williams; A Macpherson
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

6.  In vitro anticolon antibody production by mucosal or peripheral blood lymphocytes from patients with ulcerative colitis.

Authors:  T Hibi; M Ohara; K Toda; A Hara; H Ogata; Y Iwao; N Watanabe; M Watanabe; Y Hamada; K Kobayashi
Journal:  Gut       Date:  1990-12       Impact factor: 23.059

7.  The problem of chronic inflammatory bowel disease.

Authors:  D W Watson
Journal:  Calif Med       Date:  1972-07

8.  Pernicous anaemia, hypogammaglobulinaemia, and altered lymphocyte reactivity. A family study.

Authors:  E W Gelfand; A I Berkel; H A Godwin; R E Rocklin; J R David; F S Rosen
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

9.  The colon mucus antibody.

Authors:  N M Gibbs; L W French
Journal:  J Clin Pathol       Date:  1971-12       Impact factor: 3.411

10.  Natural anti-intestinal goblet cell autoantibody production from marginal zone B cells.

Authors:  Daiju Ichikawa; Masanao Asano; Susan A Shinton; Joni Brill-Dashoff; Anthony M Formica; Anna Velcich; Richard R Hardy; Kyoko Hayakawa
Journal:  J Immunol       Date:  2014-12-05       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.